Opendata, web and dolomites

SPRINT SIGNED

Speech Prosody in Interaction: The form and function of intonation in human communication

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "SPRINT" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITY OF KENT 

Organization address
address: THE REGISTRY CANTERBURY
city: CANTERBURY, KENT
postcode: CT2 7NZ
website: www.kent.ac.uk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Total cost 2˙481˙196 €
 EC max contribution 2˙481˙196 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-ADG
 Funding Scheme ERC-ADG
 Starting year 2019
 Duration (year-month-day) from 2019-10-01   to  2024-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITY OF KENT UK (CANTERBURY, KENT) coordinator 2˙387˙925.00
2    THE UNIVERSITY OF EDINBURGH UK (EDINBURGH) participant 62˙096.00
3    UNIVERSITEIT LEIDEN NL (LEIDEN) participant 31˙175.00

Map

 Project objective

Intonation, the modulation of voice pitch, is essential for communication as it conveys information that helps listeners make inferences about the pragmatic intent of the speaker. Despite increased understanding of intonation’s importance, there is little agreement even about essential aspects of its structure and meaning. This is in large part because research has focused either on the form of intonation, often taking a reductive approach to meaning, or has concentrated on meaning but without full scrutiny of form. Crucially, most research has eschewed the study of intonational variability, seeing it as a problem, rather than a natural facet of speech production that needs to be understood and accounted for. Examining all three aspects in tandem is critical for understanding how intonation is structured and functions in communication: considering meaning in the study of intonational form (i.e. phonetics and phonology) can help delimit intonational categories and uncover the limits of within-category variability; in turn, a robust understanding of form will lead to insights into intonational pragmatics. The present proposal will take exactly this integrative approach, based on the PI’s recent research, to examine intonational phenomena attested in English and Greek that have vexed researchers for some time (uptalk, high accents, question tunes). Two varieties per language will be studied, Standard Southern British, Bristol English, Standard Athenian, and Corfiot Greek. Their systematic differences with respect to the phenomena under investigation will allow me to examine cross-linguistic differences, and dialectal variation and its role in communication. The investigation will involve phonetic and pragmatic analysis and modelling, followed by series of behavioural and neurophysiological experiments. Together, these methods will shed light onto the realization, structure and function of intonation, and lead to a robust model of intonational phonology and pragmatics.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SPRINT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SPRINT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

AllergenDetect (2019)

Comprehensive allergen detection using synthetic DNA libraries

Read More  

ARCTIC (2020)

Air Transport as Information and Computation

Read More  

inhibiTOR (2020)

Novel selective mTORC1 inhibitors

Read More